Health Care: Drugs

AMAG Pharmaceuticals Inc (AMAG: NASDAQ)

$45.78 -0.98 | -2.1%
01/26/15 - 03:31 PM ET
Company Profile
Price and Volume
Recent Price 46.76
52 Week High 48.50
52 Week Low 16.49
Avg. Daily Vol. (Mil) 0.51
Beta (3 year) 0.86
Share Related Items
Mkt Cap (Mil) 1,033.15
Shares Out (Mil) 22.09
Float (Mil) 15.54
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.20
Current Ratio 11.00
LT Debt/ Equity 0.84
Total Debt / Equity 0.84
Valuation Ratios
Price Earnings n.a.
Price/Sales 11.13
Price/Book 5.24
Price/Cash Flow -343.00
Per Share Data
Earnings -0.50
Sales 4.20
Book Value 8.92
Cash Flow -0.14
Business Summary
AMAG Pharmaceuticals Inc is a specialty pharmaceutical company that markets Feraheme Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA, and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucositis.
General Information
1100 Winter Street
Waltham, MA 02421
Industry : Drugs
Sector: Health Care
Employees: 148
CEO: William K. Heiden
Short Interest
Current Month (Mil) 6.96
Previous Month (Mil) 7.13
Short Interest Ratio (Days) 13.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -2.40
Return on Investments -3.00
Gross Margin 95.70
EBIT Margin -3.40
Profit Margin -11.70

Portfolios with AMAG

Latest AMAG Headlines from TheStreet

More Financial News for AMAG

Press Releases for AMAG

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter